You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 259 No. 19, May 20, 1988 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (28)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antitrypsin and Emphysema

Perspective and Prospects

John A. Pierce, MD

JAMA. 1988;259(19):2890-2895.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

AN ARRAY of serine proteinase inhibitors (serpins) modulate important proteolytic cascades in blood and tissue. A high concentration of the major serpin, {alpha}1-antitrypsin, in plasma reflects the prevalence and potential threat of its primary target enzyme, neutrophil elastase. The observation that the inherited deficiency of antitrypsin was often associated with premature airflow limitation due to panacinar emphysema led to the concept that normal lung structure depends on a balance between the destructive effects of neutrophil elastase and the protective effects of the serpins, especially {alpha}1-antitrypsin. Wide variability exists in the tendency for emphysema to develop among subjects with the deficiency, but those who smoke cigarettes become disabled 15 to 20 years earlier than those who do not.

Definitive therapy was not available until recently; the protein has been purified on a commercial scale. Early results indicate that weekly injections of antitrypsin safely sustain normal levels in . . . [Full Text PDF of this Article]


Author Affiliations

From the Medical Service, John Cochran Veterans Administration Hospital, and the Respiratory and Critical Care Division, Department of Internal Medicine, Washington University Medical Center, St Louis.


Footnotes

Reprint requests to Box 8052, Washington University Medical Center, 660 S Euclid, St Louis, MO 63110 (Dr Pierce).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.